Premarket Trading Ideas for July 1st: UWTI, GOGO, TLOG, JUNO, UVXY, XIV, ERX, VNDA, VTAE, AVAV, AAPL, DDD, LL,

IPO of the day:
TDOC great below 30.

Day Trading stocks:

UWTI, GOGO, TLOG, JUNO, BIOC, FREE, AAVL

Economic Calendar:

Session				Time	Currency	Event	Impact	Actual	Forecast	Prev.
				3:50	EUR	French Manufacturing PMI	low		50.5	50.5
				3:55	EUR	German Manufacturing PMI	med		51.9	51.9
				4:00	EUR	Manufacturing PMI	med		52.5	52.5
				8:15	USD	ADP Employment Survey	med		218	201
				9:45	USD	Manufacturing PMI	low		53.4	53.4
				10:00	USD	Construction Spending	low		0.4	2.2
				10:00	USD	ISM Manufacturing	high		53.1	52.8

Premarket Earning Report:

General Mills, Inc. ( GIS) is reporting for the quarter ending May 31, 2015. The food company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.71. This value represents a 5.97% increase compared to the same quarter last year. 

Constellation Brands Inc ( STZ) is reporting for the quarter ending May 31, 2015. The alcohol company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.22. This value represents a 14.02% increase compared to the same quarter last year. STZ missed the consensus earnings per share in the 3rd calendar quarter of 2014 by -3.48%. 

Paychex, Inc. ( PAYX) is reporting for the quarter ending May 31, 2015. The outsourcing company's consensus earnings per share forecast from the 20 analysts that follow the stock is $0.44. This value represents a 10.00% increase compared to the same quarter last year. In the past year PAYX has met analyst expectations twice and beat the expectations the other two quarters.

McCormick & Company, Incorporated ( MKC ) is reporting for the quarter ending May 31, 2015. The food company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.68. This value represents a 6.25% increase compared to the same quarter last year. In the past year MKC has beat the expectations every quarter. The highest one was in the 1st calendar quarter where they beat the consensus by 9.38%. The "days to cover" for this stock exceeds 19 days. 

Acuity Brands Inc ( AYI) is reporting for the quarter ending May 31, 2015. The building company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.33. This value represents a 33.00% increase compared to the same quarter last year. AYI missed the consensus earnings per share in the 2nd calendar quarter of 2014 by -11.5%. The days to cover, as reported in the 6/15/2015 short interest update, increased 144.76% from previous report on 5/29/2015.

Unifirst Corporation ( UNF ) is reporting for the quarter ending May 31, 2015. The uniform company's consensus earnings per share forecast from the 6 analysts that follow the stock is $1.39. This value represents a 9.15% decrease compared to the same quarter last year. In the past year UNF has beat the expectations every quarter. The highest one was in the 1st calendar quarter where they beat the consensus by 5.38%. 

AZZ Incorporated ( JAZZ) is reporting for the quarter ending May 31, 2015. The machinery company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.69. This value represents a 32.69% increase compared to the same quarter last year. 

Greenbrier Companies, Inc. ( GBX) is reporting for the quarter ending May 31, 2015. The transportation company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.60. This value represents a 55.34% increase compared to the same quarter last year. In the past year GBX has beat the expectations every quarter. The highest one was in the 1st calendar quarter where they beat the consensus by 27.64%. The "days to cover" for this stock exceeds 18 days. 

After Hour Report:

TetraLogic Pharmaceuticals Corporation (NASDAQ: TLOG) 41% HIGHER; announced preliminary data from the ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes (MDS). The study is being conducted as a precursor to the ongoing randomized Phase 2B study. In this study, birinapant was administered, at 13 mg/m2 twice a week, three weeks out of four, during a four week cycle in combination with the approved dose of azacitidine. The primary assessment of efficacy was the response rate using the modified International Working Group criteria (Cheson 2006) at the end of cycle four. Of the nine patients who entered the study, six completed four cycles of therapy and underwent a repeat bone marrow assessment. Three patients experienced a complete response, one patient experienced a bone marrow complete response, one patient experienced a partial response and underwent a stem cell transplant and one patient had stable disease. Three patients discontinued the study prior to receiving four cycles of treatment. The regimen was generally well tolerated, the most common side effects being fatigue, neutropenia and thrombocytopenia.

AeroVironment (NASDAQ: AVAV) 4.7% HIGHER; reported Q4 EPS of $0.32, $0.14 better than the analyst estimate of $0.18. Revenue for the quarter came in at $86.5 million versus the consensus estimate of $85.71 million. As of April 30, 2015, funded backlog (unfilled firm orders for which funding is currently appropriated to us under a customer contract) was $64.7 million compared to $65.9 million as of April 30, 2014. AeroVironment sees FY2016 revenue of $260-280 million, versus the consensus of $277.3 million.

Ballard Power (NASDAQ: BLDP) 4.3% LOWER; announced its intention to offer its common shares in an underwritten public offering. Ballard expects to grant the underwriters of the Offering a 30-day option to purchase up to an additional 15% of the common shares offered in the Offering to cover overallotments, if any. The Offering is subject to market conditions and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Calamp Corp. (NASDAQ: CAMP) 1.8% LOWER; reported Q1 EPS of $0.26, in-line with the analyst estimate of $0.26. Revenue for the quarter came in at $65.4 million versus the consensus estimate of $65.39 million. Calamp Corp. sees Q2 2015 EPS of $0.24-$0.28, versus the consensus of $0.26. Calamp Corp. sees Q2 2015 revenue of $66-70 million, versus the consensus of $68.08 million. Calamp Corp. sees FY2015 revenue of $280-290 million compared to the consensus of $282.77 million.

Apollo Investment (NASDAQ: AINV) 1.3% HIGHER; Jefferies initiated coverage with a Buy rating and a price target of $8.50.

Kohlberg Capital (NASDAQ: KCAP) 0.7% HIGHER; Cantor Fitzgerald initiated coverage with a Hold rating and a price target of $6.50.